The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Dr. Bazhenova on the Prevalence of Patients With Non-Driver NSCLC

Lyudmila A. Bazhenova, MD
Published Online: Sep 01,2017

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses the prevalence of patients with non-driver non–small cell lung cancer.


Clinical Articles

Dr. Bazhenova on the Prevalence of Patients With Non-Driver NSCLC
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.